Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients

Hepato-Gastroenterology

Volumn 54, Issue 77, 2007, Pages 1438-1442

  Hadi Yasa, Mehmet ^a   Bolaman, Zahit ^a   Yukselen, Vahit ^a   Kadikoylu, Gurhan ^a   Karaoglu, Ali Onder ^a   Batun, Sabri ^b  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

Factor V Leiden G1691A; Gene mutation; Inflammatory bowel disease; Methylene tetrahydrofolate reductase C677T; Prothrombin G20210A

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIBIOTIC AGENT; AZATHIOPRINE; BLOOD CLOTTING FACTOR 5; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; PROTHROMBIN; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA EXTRACTION; ENTERITIS; FEMALE; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERCOAGULABILITY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOEMBOLISM; TURKEY (REPUBLIC); ULCERATIVE COLITIS;

ADULT; AGED; FACTOR V; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PROTHROMBIN; TURKEY;

EID: 34547633637     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Wakfield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AAM: Pathogenesis of Crohn's disease: multifocal intestinal infarction. Lancet 1989; 2:1057-1062.
2. Papa A, Stefano VD, Gasbarrini P, Chiusolo R, Cianci I, Casorelli K, et al: Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease. Blood Coag Fibrinol 2000; 11:599-603.
3. Magro F, Dinis-Ribeiro M, Araujo FM, Pereira P, Fraga MJ, Cunha-Ribeiro LM, et al: High prevalence of combined thrombophdic abnormalities in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2003; 15:1157-1163.
4. Talbot RW, Heppell J, Dozois RR, Beart RW Jr: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61:140-145.
5. Solem CA, Loftus EV, Tremaine WJ, Sandhorn WJ: Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2003; 99:97-101.
6. Over HH, Ulgen S, Tuglular T, Tezel A, Avsar E, Geyik G, et al: Thrombophilia and inflammatory bowel disease: Does factor V mutation have a role? Eur J Gastroenterol Hepatol 1998; 10:827-829.
7. Jackson LM, O'Gorman PJ, O'Connell J, Cronin CC, Cotter KP, Shanahan F: Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor V Leiden. QJM 1997; 90:183-188.
8. Mahmut N, Molloy A, McPartlin J, Corbally R, Whitehead AS, Scott JM, et al: Increased prevalence of methylenetetrahydrafolate reductase in patients with inflammatory bowel disease, and its clinical implications. Gut 1999; 45:389-394.
9. Koutrobakis IE, Sfiridaki A, Mouzas IA, Maladaki A, Kapsoritakis A, Roussomoustakaki M, et al: Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2003; 95:190-194.
10. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci 1993; 90:1004-1008.
11. Svensson PJ, Dahlback B: Resistance to Activated Protein C as a Basis for Venous Thrombosis. N Engl J Med 1994; 330:517-522.
12. Seligsohn U, Libertsky A: Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344:1222-1231.
13. Liebman HA, Kashani N, Sutherland D, McGehee W, Kam AL: The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology 1998; 115:830-834.
14. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
15. Vecchi M, Sacchi E, Saibeni S, Meucci G, Tagliabue L, Duca F, et al: Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 2000; 45:1465-1469.
16. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703.
17. Rosendaal FR, Doggen CJM, Zivelin A, Arruda VR, Aiachm M, Sickocick DS, et al: Geographic distribution of the prothrombin 20210 G to A prothrombin variant. Thromb Haemost 1998; 79:706-708.
18. Huisman MV, Rosendal F: Thrombophilia. Curr Opin Hematol 1999; 6:291-297.
19. Ramacciotti E, Wolosker N, Puech-Leao P, Zeratti EA, Gusson PR, delGiglio A, et al: Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis. Thrombos Res 2003; 109:171-174.
20. Papa A, Danese S, Grillo A, Gasbarinni G, Gasbarinni A: Review article: Inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 2003; 98:1247-1251.
21. Sloan WP, Bargen Ja, Gage RB: Life histories of patients with chronic ulcerative colitis: A review of 2,000 cases. Gastroenterology 1968; 54:819-822.
22. Graef V, Baggenstoss AH, Sauer WG, Spittel J: Venous thrombosis occurring in non-specific ulcerative colitis. A necropsy study. Arch Intern Med 1966; 117:377-382.
23. Gaffney PR, Doyle CT, Gaffney A, Hogan J, Hayes PP, Annis P: Paradoxal response to heparine in 10 patients with ulcerative colitis. Am J Gastroentrol 1995; 90:220-223.
24. Thompson NP, Wakefield AJ, Pounder RE: Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995; 108:110-115.
25. Zoller B, Svensson PJ, He X, Dahlback B: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94:2521-2524.
26. Rosendal FR, Koster T, Vonderbraucke JP, Reitsma PH: High-risk of thrombosis in patients homozygous factor V Leiden (acquired protein C resistance). Blood 1995; 85:1504-1511.
27. Lane DA and Grant PJ: Role of hemostatic gene polymorphism in venous and arterial thrombotic disease. Blood 2000; 95:1517-1532.
28. De Stefano V, Martinelli I, Mannucci PM, Paciaruni K, Chiusolo P, Casonelli I, et al: The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and G20210A prothrombin mutation. N Engl J Med 1999; 341:801-806.
29. Grip O, Svensson PJ, Lindgren S: Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000; 35:619-623.
30. Zauber NP, Sabbath-Solitare M, Rajoria G, Morgan G: Factor V Leiden mutation is not increased in patients with inflammatory bowel disease. J Clin Gastroenterol 1998; 27:215-216.
31. Turri D, Rosselli M, Simioni P, Tormene D, Grimaudo S, Martorana G, et al: Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area. Dig Liv Dis 2001; 33:559-562.
32. Vecchi M, Sacchi E, Saibeni S, Meucci G, Tagliabue L, Duca F, et al: Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 2000; 45:1465-1469.
33. Helio T, Wartiovaara U, Halme L, Turunen UM, Mikkola H, Palotie A, et al: Arg506Gln factor V mutation and Val34Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease. Scand J Gastroenterol 1999; 34:170-174.
34. Guedon C, Le Cam-Duchez V, Lalaude O, Menard JF, Levebours E, Borg JY: Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease. Am J Gastroenterol 2001; 96:1448-1454.
35. Nagy Z, Nagy A, Karadi O, Par A, Mozsik G: The high prevalence of the factor V Leiden mutation in central European inflammatory bowel disease patients. Am J Gastroenterol 2000; 95:3013-3014.
36. Haslam N, Standen GR, Probert CS: An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11:1289-1291.
37. Hillarp A, Zoller B, Svensson P, Dahlback B: The 20210A allele the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78:990-992.
38. Bjerregaard LT, Nederby T, Fredholm L, Brandslund I, Munkholm P, Hey H: Hyperhomocysteinemia, coagulation pathway activation and thrombophilia in patients inflammatory bowel disease. Scand J Gastroenterol 2002; 37:62-67.
39. Seinost G, Renner W, Brodmann M, Winkler M, Koppel H, Pilger E: C677T Mutation in the Methylene Tetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombotic Disease in Austrian Patients. Thrombos Res 2000; 100:405-407.
40. Papa A, De Stefano V, Danese S, Chiusolo P, Persichilli S, Casorelli I, et al: Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96:2677-2682.
41. Botto LD, Yang Q: 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalities: A HuGe review. Am J Epidemiol 2000; 151:862-877.